DR. PAUL M. COADY, MD

WYNNEWOOD, PA

Research Active
Internal Medicine - Interventional Cardiology NPI registered 21+ years 13 publications 2000 – 2026 NPI: 1255336277
Endovascular ProceduresSuture TechniquesRobotic Surgical ProceduresCoronary Artery DiseaseRegistriesEquipment DesignAortic Aneurysm, AbdominalCatheterization, PeripheralTranscatheter Aortic Valve ReplacementPercutaneous Coronary InterventionPuncturesAngioplasty, Balloon, CoronaryHemorrhageHemostatic TechniquesVascular Closure Devices

Practice Location

100 LANCASTER AVE.
WYNNEWOOD, PA 19096-3450

Phone: (484) 476-1000

What does PAUL COADY research?

Dr. Coady studies a range of issues primarily related to heart conditions and hormonal balance in men. His work includes the effects of heart failure and treatment procedures like transcatheter edge-to-edge repair for leaking heart valves, providing insights into patient outcomes. He also explores unique hormonal conditions, such as congenital aromatase deficiency, which affects men's hormone metabolism. This research has significant implications for understanding how hormone treatments can restore health without impacting fertility. Additionally, his studies assess innovative devices for closing blood vessels after surgeries, contributing to faster recovery and fewer complications for patients.

Key findings

  • In his study on congenital aromatase deficiency, a male patient reported improved energy levels and libido after just three months of estrogen supplementation, indicating successful hormone restoration.
  • In patients with heart failure undergoing transcatheter edge-to-edge repair, those with mixed heart failure had significantly worse outcomes, with increased risks of death and heart-related events compared to others.
  • The Cross-Seal device demonstrated effectiveness in stopping bleeding in an average of 0.4 minutes after minimally invasive procedures, with major complications occurring in only 9.2% of cases.
  • For robotic-assisted heart surgery patients, the death rate over an average of 4.2 years was 10.9%, while serious heart-related complications occurred in 35.9% of patients, indicating the procedure's viability.
  • Analyses of percutaneous coronary intervention showed that patients with congestive heart failure had higher in-hospital death rates (2.6%) compared to those without (0.4%), highlighting the need for targeted improvements in care.

Frequently asked questions

Does Dr. Coady study heart diseases?
Yes, Dr. Coady conducts extensive research on various heart conditions, including heart failure and surgical interventions.
What treatments has Dr. Coady researched?
Dr. Coady has researched hormonal treatments for men, innovative heart procedures, and devices that aid in surgical recovery.
Is Dr. Coady's work relevant to men with hormonal issues?
Absolutely, Dr. Coady's research provides crucial insights into how estrogen therapy can benefit men with hormonal deficiencies.
What is the significance of his studies on new medical devices?
His studies on new devices, like the Cross-Seal and MANTA, show how they can effectively reduce complications and improve recovery times after heart and vascular surgeries.
How does Dr. Coady's work impact patient outcomes in surgery?
Dr. Coady's research highlights advancements in surgical methods that lead to safer operations and better long-term outcomes for patients.

Publications in plain English

Congenital aromatase deficiency in an adult male: A case report of clinical course and symptom reversal with estrogen supplementation.

2026

Urology case reports

Coady P, Walia A, Hernandez B, Hinojosa-Gonzalez DE, El-Achkar A +1 more

Plain English
This study focused on a man with a rare genetic condition that prevents his body from converting male hormones into female hormones, causing symptoms like extreme tiredness and low sex drive. After three months of treatment with a small dose of estrogen, he reported feeling much more energetic and interested in sex, and medical tests showed his hormone levels returned to normal while he was still able to produce sperm. This finding is important because it highlights how necessary estrogen is for men's health and shows that giving estrogen can improve symptoms without harming fertility. Who this helps: This benefits men with hormone-related issues, doctors treating hormonal imbalances, and fertility specialists.

PubMed

Long-term clinical outcomes of robotic-assisted surgical coronary artery revascularisation.

2024

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Dokollari A, Sicouri S, Erten O, Gray WA, Shapiro TA +12 more

Plain English
This study looked at the long-term results of robotic-assisted heart surgery for patients who weren't able to undergo traditional bypass surgery. It involved 2,280 patients over several years, and researchers found that as time went on, patients were older and surgery times got shorter (from an average of 6.4 hours to 5.5 hours). Importantly, the rates of serious complications and death decreased significantly over time, showing that this new method leads to better outcomes for patients. Who this helps: Patients with heart conditions who cannot have traditional surgery.

PubMed

Midterm Clinical Outcomes of Robotic-Assisted Reverse Hybrid Coronary Revascularization: A Single-Center Experience.

2024

The American journal of cardiology

Dokollari A, Gemelli M, Sicouri S, Gray WA, Shapiro TA +19 more

Plain English
This study looked at the results of a special heart surgery called robotic-assisted reverse hybrid coronary revascularization (HCR) in 285 patients over several years. They found that after an average of 4.2 years, 10.9% of patients had died from various causes, and 35.9% experienced serious heart or brain-related issues, although complications like strokes and reoperations were rare. This matters because it indicates that this surgery can be effective and safe for patients with complex heart blockages. Who this helps: Patients with multivessel coronary artery disease.

PubMed

Clinical Outcomes and Cost Analysis in Patients with Heart Failure Undergoing Transcatheter Edge-to-Edge Repair for Mitral Valve Regurgitation.

2024

Journal of personalized medicine

Dokollari A, Sicouri S, Rodriguez R, Gnall E, Coady P +16 more

Plain English
This study looked at how a heart procedure called transcatheter edge-to-edge repair (TEER) affects patients with different types of heart failure who also have a leaky heart valve. Researchers found that patients with mixed heart failure had the worst outcomes, including a much higher risk of death and major heart-related events, while no significant differences in hospital costs were found among the different patient groups. Understanding these differences is important for improving treatment strategies and patient care for those with heart failure. Who this helps: This helps doctors and healthcare providers better manage treatment for heart failure patients.

PubMed

Cross-Seal IDE Trial: Prospective, Multicenter, Single-Arm Study of the Cross-Seal Suture-Mediated Vascular Closure Device System.

2024

Circulation. Cardiovascular interventions

Krishnan P, Farhan S, Zidar F, Krajcer Z, Metzger C +16 more

Plain English
This study looked at a new device called the Cross-Seal, which is designed to close blood vessels after certain medical procedures that use large tubes. The researchers found that the device allows doctors to stop bleeding quickly, taking just 0.4 minutes on average, and it was effective in about 92% of cases. Only 9.2% of patients needed extra help to control bleeding, and 94.3% faced no major complications after the procedure. Who this helps: This benefits patients undergoing procedures that require large-sheath technology, as it can lead to safer and faster recovery.

PubMed

Epinephrine Administered in Anaphylaxis: The Evolution of 0.3 mg Dosage.

2023

Therapeutic advances in allergy and rhinology

Coady P, Dretchen KL, Mesa M

Plain English
This study looked at the history of the 0.3 mg dosage of epinephrine used to treat severe allergic reactions known as anaphylaxis. It traced how this specific dose was chosen and supported by earlier clinical observations, showing how the understanding of epinephrine usage has developed over time. This matters because it helps clarify why this dosage is used today in EpiPens, ensuring that patients receive effective treatment during emergencies. Who this helps: This benefits patients at risk of anaphylaxis and their caregivers.

PubMed

A Qualitative Examination of the Impact of Suicidal Thoughts and Behavior on Help-Seeking Among University Students in Colombia and Mexico.

2023

Journal of behavioral and cognitive therapy

Castro-Ramirez F, Paz-Pérez MA, McGuire TC, Rankin O, Alfaro MCG +13 more

Plain English
This study explored how suicidal thoughts and behaviors affect university students in Colombia and Mexico and what factors influence their willingness to seek help. Researchers interviewed 55 students who reported emotional difficulties, finding that many experienced physical symptoms during crises and often felt a strong desire to avoid causing suffering to their families, which helped protect them from suicide. However, cultural shame surrounding mental illness led many to hide their struggles and avoid seeking treatment. Who this helps: This information benefits students struggling with mental health issues, as well as the doctors and counselors working to support them.

PubMed

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device.

2019

Circulation. Cardiovascular interventions

Wood DA, Krajcer Z, Sathananthan J, Strickman N, Metzger C +42 more

Plain English
This study looked at a new device called the MANTA, designed to safely close large holes in blood vessels after certain heart and vascular surgeries. Researchers tested it on 341 patients and found that it effectively stopped bleeding in most cases: patients had a mean time of about 24 seconds to achieve hemostasis, and only 4.2% experienced serious complications. This is important because it could lead to quicker recovery times and fewer complications for patients undergoing these procedures. Who this helps: Patients undergoing heart and vascular surgeries.

PubMed

Delayed bilateral fibrinous anterior chamber reaction following autologous bone marrow transplant and cataract surgery.

2016

American journal of ophthalmology case reports

Kavoussi SC, Kovacs KD, Alasil T, Coady P, Kombo N

Plain English
This study examined a patient who developed inflammation in the eye months after having cataract surgery and undergoing a bone marrow transplant for cancer treatment. The inflammation was linked to a quick recovery of her white blood cell count after temporary immunosuppression from chemotherapy. Importantly, her symptoms improved with steroid treatment, suggesting similar mechanisms to those seen in patients with AIDS. Who this helps: This research benefits patients recovering from similar treatments and their doctors by providing insight into potential eye complications.

PubMed

All at once: multivessel spontaneous coronary artery dissection with right coronary artery ST-segment elevation myocardial infarction.

2014

JACC. Cardiovascular interventions

Sardar MR, Pieczynski LM, Saeed W, Domsky SM, Shapiro TA +1 more

PubMed

The army health hazard assessment program's medical cost-avoidance model.

2010

American journal of preventive medicine

Bratt GM, Kluchinsky TA, Coady P, Jordan NN, Jones BH +1 more

Plain English
This study focuses on improving a model used by the Army to estimate costs related to health hazards associated with military equipment. The updated model now considers specific health hazards and their associated costs, rather than using a single cost estimate for all hazards, which will help better identify risks to soldiers. This matters because it enables the Army to prioritize addressing health hazards that could negatively impact soldier health and operational readiness. Who this helps: Patients, specifically soldiers and military personnel.

PubMed

The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: an analysis of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic Registry.

2006

American heart journal

Holper EM, Blair J, Selzer F, Detre KM, Jacobs AK +6 more

Plain English
This study looked at patients with congestive heart failure (CHF) who underwent a procedure to open blocked heart arteries, called percutaneous coronary intervention (PCI). It found that patients with CHF had a higher chance of dying compared to those without CHF, with in-hospital death rates at 2.6% versus 0.4% and one-year death rates at 13.1% versus 3.0%. However, over the years, improvements in treatment methods and medications have led to better outcomes for CHF patients undergoing PCI. Who this helps: This information is valuable for doctors treating patients with heart failure.

PubMed

Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries.

2000

Circulation

Williams DO, Holubkov R, Yeh W, Bourassa MG, Al-Bassam M +15 more

Plain English
This study compared two groups of patients who underwent heart procedures: one group from 1985-1986 and another from 1997-1998. The later group was older, more often female, and had more serious heart conditions, yet their procedures were more successful (92% vs. 82% success) and they faced fewer complications, including a lower risk of needing emergency bypass surgery or follow-up operations (4.9% vs. 7.9%). These improvements highlight how advances in heart treatments have made procedures safer and more effective over the years. Who this helps: This helps patients with heart conditions.

PubMed

Frequent Co-Authors

Aleksander Dokollari Serge Sicouri Eric Gnall Stephanie Kjelstrom Georgia Montone Basel Ramlawi Timothy A Shapiro Roberto Rodriguez Beatrice Bacchi Ashish Shah

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.